EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Wed, 30.04.2025
Dräger with strong demand in the first quarter of 2025
Order intake exceeds high prior-year figure
Net sales close to prior-year level
Operating result narrowly positive
Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first quarter of 2025 thanks to strong demand. At around EUR 861 million, order intake exceeded the high ...
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
Lübeck, April 14, 2025 – In the first quarter, which is seasonally weak for Dräger, the Company generated slightly positive earnings before interest and taxes...
Dräger increases net profit in fiscal year 2024 and raises dividend
Order intake exceeds high prior-year level
Net sales close to strong prior-year figure
EBIT up around 17 percent
Good business performance in the fourth quarter
Higher dividend for 2024: EUR 1.97 per common share (2023: EUR 1.74) and EUR 2.03 per preferred share (2023: EUR 1.8...
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
The share buyback of Drägerwerk AG & Co. KGaA (“Dräger”), which had begun on October 7, 2024, was completed on January 20, 2025. A total of 77,316 preferred shares were bought back during this period. The start of the buyback w...
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations –Forecast 2025
Lübeck, January 15, 2025 – Based on preliminary calculations, Dräger's net sales in fiscal year 2024 increased by 0.6 percent (net of currency effects; nominal: ...
Changes in the chair of the Dräger Supervisory Board
Lübeck – Stefan Lauer, currently Chairman of all Dräger Supervisory Boards, has decided to step down as Chairman at the end of the year for health reasons. The Supervisory Board committees approved this move at their meetings today and passed the following resolutions:
From January 1, 2025, the...
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission: Extension of the share buyback for the employee stock program
On September 2, 2024, the Executive Board of Drägerwerk Verwaltungs AG had resolved a share buyback for the employee stock program of Dräge...
Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024
Order intake exceeds high prior-year level
Net sales almost reach the strong prior-year figure
EBIT up around four percent
Annual forecast confirmed
Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first nine months ...
Dräger with good demand in the first nine months of 2024
Order intake exceeds the high prior-year level
Net sales almost reach the strong prior-year figure
EBIT up around four percent
Annual forecast confirmed
Lübeck – Dräger's preliminary order intake rose by 1.4 percent (net of currency effects; nominal: 0.7 percent) to around EUR 2,421 milli...
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
On September 2, 2024, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back some...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .